KOR  ENG

앱클론 로고

Contact

AC101

ac101

Boosting treatment efficacy of breast and gastric cancer

AC101 is a monoclonal therapeutic antibody for the treatment of HER2 expressing breast and gastric cancer

  • AC101
  • AC101 is a monoclonal antibody that binds to a unique site of the HER2 disease protein
    (compared to commercialized antibodies such as Herceptin and Perjeta). When used in
    combination with Herceptin, AC101 boasts better anticancer efficacy in breast / gastric
    cancer animal than the traditional Herceptin & Perjeta combination. AC101 is currently
    undergoing clinical trials after being transferred to Shanghai Henlius Biotech.

Anticancer Efficacy in vivo

Decisive elimination and suppression of gastric cancer cells

AC101 위암 동물모델 AC101
Designed by CHAIRONE
  • 앱클론 로고
  • AbClon Inc. #1401 285, Digital-ro, Guro-gu, Seoul, Republic of Korea
    T. +82-2109-1294
    F. +82-2109-1296
    E. abclon@abclon.com
About us
Overview CAR-T GMP History Collaboration Contact Us
Technology
CAR-T platform NEST platform AffiMab platform
Pipeline
AT101 AT501 AC101 AM201 AM105 AM109
Antibody Service
Antibody Service
IR/PR
News Stock IR Information
© AbClon. All rights reserved.